India to Vietnam: Tacrolimus Export Trade Route

The India to Vietnam Tacrolimus corridor is one of India's established pharmaceutical export routes, with 150 shipments documented worth a combined $22.9M USD. The route is dominated by THE MADRAS PHARMACEUTICAL, which alone accounts for roughly 98% of all export value, reflecting the consolidated nature of India's tacrolimus manufacturing sector.

Across 13 active suppliers, the average shipment value stands at $152.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 82% of all shipments, consistent with tacrolimus's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 21 days port-to-port. The route has recorded an annual growth rate of 34.0%, placing it at rank #3 among India's top tacrolimus export destinations globally.

On the import side, key buyers of Indian tacrolimus in Vietnam include SAIGON PHARMACEUTICAL COMPANY LTD, SAIGON PHARMACEUTICAL COMPANY LTD , HAPHARCO J S C BRANCH and 26 others. SAIGON PHARMACEUTICAL COMPANY LTD is the single largest importer with 10 shipments valued at $22.5M USD.

India's tacrolimus exports to Vietnam are driven primarily by a handful of large-scale manufacturers. THE MADRAS PHARMACEUTICAL with 8 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 13 active exporters signals a competitive but concentrated market — buyers in Vietnam benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — THE MADRAS PHARMACEUTICAL, THE MADRAS PHARMACEUTICALS, THE MADRAS PHARMACEUTICAL — together account for 99% of total trade value on this route. The average shipment value of $152.8K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as rocimus 0.03% w/w (tacrolimus ointment 0 and rocimus 0.1% w/w (tacrolimus ointment 0. , suggesting that buyers in Vietnam tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, SAIGON PHARMACEUTICAL COMPANY LTD is the largest importer with 10 shipments worth $22.5M USD — representing 98% of all tacrolimus imports from India on this route. A total of 29 buyers are active on this corridor.